ANNEXON, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

Attached hereto as Exhibit 99.1 is an investor presentation that Annexon, Inc. (the "Company") plans to present during the 40th Annual J.P. Morgan Healthcare Conference commencing on January 10, 2022.

The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 and in the presentation attached as Exhibit 99.1 to this Current Report shall not be incorporated by reference into any filing with the Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.   Description

99.1            Company Presentation.

104           Cover Page Interactive Data File, formatted in inline XBRL.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses